References
- Basu S, Millett C. Social epidemiology of hypertension in middle-income countries: determinants of prevalence, diagnosis, treatment, and control in the WHO SAGE study. Hypertension 62(1), 18–26 (2013).
- WHO. A Global Brief on Hypertension. Silent Killer, Global Public Health Crisis. World Health Organization, Geneva, Switzerland (2013).
- Beaglehole R, Bonita R, Horton R et al. Priority actions for the non-communicable disease crisis. Lancet 377(9775), 1438–1447 (2011).
- Lawes CM, Vander Hoorn S, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet 371(9623), 1513–1518 (2008).
- Chow CK, Teo KK, Rangarajan S et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA 310(9), 959–968 (2013).
- Lopez-Jaramillo P, Lahera V, Lopez-Lopez J. Epidemic of cardiometabolic diseases: a Latin American point of view. Ther. Adv. Cardiovasc. Dis. 5(2), 119–131 (2011).
- Harrison M, Maresso K, Broeckel U. Genetic determinants of hypertension: an update. Curr. Hypertens. Rep. 10(6), 488–495 (2008).
- Anand SS, Yusuf S. Stemming the global tsunami of cardiovascular disease. Lancet 377(9765), 529–532 (2011).
- Lopez-Jaramillo P, Silva SY, Rodriguez-Salamanca N et al. Are nutrition-induced epigenetic changes the link between socioeconomic pathology and cardiovascular diseases? Am. J. Ther. 15(4), 362–372 (2008).
- Ehret GB, Munroe PB, Rice KM et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 478(7367), 103–109 (2011).
- Lopez-Jaramillo P. Cardiometabolic disease in Latin America: the role of fetal programming in response to maternal malnutrition. Rev. Esp. Cardiol. 62(6), 670–676 (2009).
- Wang Y, Liang Y, Lu Q. MicroRNA epigenetic alterations: predicting biomarkers and therapeutic targets in human diseases. Clin. Genet. 74(4), 307–315 (2008).
- Fernandes MT, Sesso R, Martins PA et al. Increased blood pressure in adolescents of low socioeconomic status with short stature. Pediatr. Nephrol. 18(5), 435–439 (2003).
- Florencio TT, Ferreira HS, Cavalcante JC et al. Short stature, obesity and arterial hypertension in a very low income population in north-eastern Brazil. Nutr. Metab. Cardiovasc. Dis. 14(1), 26–33 (2004).
- Langley-Evans SC. Critical differences between two low protein diet protocols in the programming of hypertension in the rat. Int. J. Food Sci. Nutr. 51(1), 11–17 (2000).
- Bogdarina I, Welham S, King PJ et al. Epigenetic modification of the renin-angiotensin system in the fetal programming of hypertension. Circ. Res. 100(4), 520–526 (2007).
- Franco MC, Casarini DE, Carneiro-Ramos MS et al. Circulating renin-angiotensin system and catecholamines in childhood: is there a role for birth weight? Clin. Sci. (Lond.) 114(5), 375–380 (2008).
- Bautista LE, Lopez-Jaramillo P, Vera LM et al. Is C-reactive protein an independent risk factor for essential hypertension? J. Hypertens. 19(5), 857–861 (2001).
- López-Jaramillo P, Velandia-Carrillo C, Alvarez-Camacho J, Cohen DD, Sánchez-Solano T, Castillo-López G. Inflammation and hypertension: are there regional differences?. Int. J. Hypertens. 2013, 492094 (2013).
- Rueda-Clausen CF, Lahera V, Calderon J et al. The presence of abdominal obesity is associated with changes in vascular function independently of other cardiovascular risk factors. Int. J. Cardiol. 139(1), 32–41 (2010).